2015 Q3 Form 10-Q Financial Statement

#000104396115000014 Filed on August 14, 2015

View on sec.gov

Income Statement

Concept 2015 Q3 2015 Q2 2014 Q2
Revenue $330.0K $442.0K $6.764M
YoY Change -91.88% -93.47% -7.42%
Cost Of Revenue $445.0K $465.0K $4.371M
YoY Change -81.04% -89.36% 0.88%
Gross Profit -$115.0K -$23.00K $2.393M
YoY Change -106.7% -100.96% -19.51%
Gross Profit Margin -34.85% -5.2% 35.38%
Selling, General & Admin $1.686M $1.908M $5.563M
YoY Change -66.7% -65.7% 11.66%
% of Gross Profit 232.47%
Research & Development $455.0K $468.0K $785.0K
YoY Change -29.02% -40.38% -14.02%
% of Gross Profit 32.8%
Depreciation & Amortization $100.0K $558.0K $488.0K
YoY Change -83.02% 14.34% -28.97%
% of Gross Profit 20.39%
Operating Expenses $2.141M $2.376M $6.348M
YoY Change -62.46% -62.57% 7.68%
Operating Profit -$2.256M -$2.399M -$3.955M
YoY Change -43.42% -39.34% 35.35%
Interest Expense $210.0K -$460.0K $50.00K
YoY Change -200.0% -1020.0% 0.0%
% of Operating Profit
Other Income/Expense, Net -$6.000K $0.00 $0.00
YoY Change 500.0%
Pretax Income -$2.051M -$2.855M -$3.901M
YoY Change -51.17% -26.81% 35.78%
Income Tax $0.00 -$1.000K -$8.000K
% Of Pretax Income
Net Earnings -$7.299M -$3.275M -$3.893M
YoY Change 9023.75% -15.87% 35.79%
Net Earnings / Revenue -2211.82% -740.95% -57.55%
Basic Earnings Per Share
Diluted Earnings Per Share -$243.3M -$109.3M -$194.5M
COMMON SHARES
Basic Shares Outstanding 13.87M shares 12.16M shares 7.354M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q3 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.790M $2.310M $1.190M
YoY Change 217.05% 94.12% -81.38%
Cash & Equivalents $2.787M $2.309M $1.191M
Short-Term Investments
Other Short-Term Assets $534.0K $826.0K $879.0K
YoY Change -68.84% -6.03% -18.84%
Inventory $2.619M $4.009M
Prepaid Expenses
Receivables $9.252M $9.719M $7.298M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $16.10M $15.47M $13.38M
YoY Change 17.63% 15.67% -32.84%
LONG-TERM ASSETS
Property, Plant & Equipment $303.0K $1.320M $1.836M
YoY Change -81.66% -28.1% -14.64%
Goodwill $6.918M $6.918M $6.918M
YoY Change 0.0% 0.0% 0.0%
Intangibles $1.000M $7.549M $8.665M
YoY Change -87.97% -12.88% -12.84%
Long-Term Investments
YoY Change
Other Assets $125.0K $149.0K $295.0K
YoY Change -54.71% -49.49% -32.34%
Total Long-Term Assets $8.346M $15.94M $17.71M
YoY Change -51.36% -10.04% -8.91%
TOTAL ASSETS
Total Short-Term Assets $16.10M $15.47M $13.38M
Total Long-Term Assets $8.346M $15.94M $17.71M
Total Assets $24.45M $31.41M $31.09M
YoY Change -20.74% 1.02% -21.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.732M $4.743M $3.537M
YoY Change 10.45% 34.1% 102.35%
Accrued Expenses $2.368M $2.698M $2.040M
YoY Change 20.82% 32.25% -10.76%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $6.275M $2.825M $691.0K
YoY Change 353.72% 308.83% -4.95%
Total Short-Term Liabilities $16.15M $13.31M $9.761M
YoY Change 64.6% 36.39% 23.34%
LONG-TERM LIABILITIES
Long-Term Debt $525.0K $4.850M $6.211M
YoY Change -90.64% -21.91% -14.6%
Other Long-Term Liabilities $886.0K $1.762M $1.897M
YoY Change -55.0% -7.12% 53.6%
Total Long-Term Liabilities $1.411M $6.612M $8.108M
YoY Change -81.39% -18.45% -4.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.15M $13.31M $9.761M
Total Long-Term Liabilities $1.411M $6.612M $8.108M
Total Liabilities $17.73M $20.49M $20.74M
YoY Change -13.98% -1.23% 13.06%
SHAREHOLDERS EQUITY
Retained Earnings -$194.1M -$186.8M -$177.1M
YoY Change 9.34% 5.46% 11.66%
Common Stock $139.0K $123.0K $73.00K
YoY Change 90.41% 68.49% -91.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.717M $10.92M $10.35M
YoY Change
Total Liabilities & Shareholders Equity $24.45M $31.41M $31.09M
YoY Change -20.74% 1.02% -21.01%

Cashflow Statement

Concept 2015 Q3 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income -$7.299M -$3.275M -$3.893M
YoY Change 9023.75% -15.87% 35.79%
Depreciation, Depletion And Amortization $100.0K $558.0K $488.0K
YoY Change -83.02% 14.34% -28.97%
Cash From Operating Activities -$3.430M -$2.500M -$3.390M
YoY Change -13.16% -26.25% 43.64%
INVESTING ACTIVITIES
Capital Expenditures -$90.00K -$180.0K -$60.00K
YoY Change 800.0% 200.0% -76.92%
Acquisitions
YoY Change
Other Investing Activities $1.950M -$60.00K -$10.00K
YoY Change -46.58% 500.0% -66.67%
Cash From Investing Activities $1.860M -$240.0K -$80.00K
YoY Change -48.9% 200.0% -73.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.040M -340.0K 2.910M
YoY Change 20300.0% -111.68% 120.45%
NET CHANGE
Cash From Operating Activities -3.430M -2.500M -3.390M
Cash From Investing Activities 1.860M -240.0K -80.00K
Cash From Financing Activities 2.040M -340.0K 2.910M
Net Change In Cash 470.0K -3.080M -560.0K
YoY Change -256.67% 450.0% -58.21%
FREE CASH FLOW
Cash From Operating Activities -$3.430M -$2.500M -$3.390M
Capital Expenditures -$90.00K -$180.0K -$60.00K
Free Cash Flow -$3.340M -$2.320M -$3.330M
YoY Change -15.23% -30.33% 58.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001043961
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13872510 shares
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
TRANSGENOMIC INC
tbio Accounts Receivable General Payment Terms1
AccountsReceivableGeneralPaymentTerms1
P30D
tbio Accounts Receivable International Extended Payment Terms Greaterthan1
AccountsReceivableInternationalExtendedPaymentTermsGreaterthan1
P90D
tbio Class Of Warrant Or Right Number Of Issued Warrants Or Rights
ClassOfWarrantOrRightNumberOfIssuedWarrantsOrRights
115432 shares
tbio Effective Tax Rate Reconciliation Permanent Differences Goodwill Amortization
EffectiveTaxRateReconciliationPermanentDifferencesGoodwillAmortization
100000 USD
tbio Fair Value Assumptions Percentage Of Simulated Equity Values Below Down Round Financing Cut Off Point
FairValueAssumptionsPercentageOfSimulatedEquityValuesBelowDownRoundFinancingCutOffPoint
0.25
tbio Class Of Warrant Or Right Number Of Issued Warrants Or Rights
ClassOfWarrantOrRightNumberOfIssuedWarrantsOrRights
1208491 shares
CY2014Q4 tbio Dividends Preferred Stock Cash Not Declared
DividendsPreferredStockCashNotDeclared
3100000 USD
CY2015Q2 tbio Dividends Preferred Stock Cash Not Declared
DividendsPreferredStockCashNotDeclared
3800000 USD
CY2015Q2 tbio Finite Lived Intangible Assets Amortization Expense Current Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseCurrentFiscalYear
1400000 USD
CY2014Q4 tbio Furniture Fixtures And Leasehold Improvements Gross
FurnitureFixturesAndLeaseholdImprovementsGross
3877000 USD
CY2015Q2 tbio Furniture Fixtures And Leasehold Improvements Gross
FurnitureFixturesAndLeaseholdImprovementsGross
3877000 USD
CY2014Q2 tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-146000 USD
tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-328000 USD
CY2015Q2 tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-186000 USD
tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-376000 USD
CY2014Q2 tbio Inventory Additions
InventoryAdditions
0 USD
tbio Inventory Additions
InventoryAdditions
55000 USD
CY2015Q2 tbio Inventory Additions
InventoryAdditions
328000 USD
tbio Inventory Additions
InventoryAdditions
328000 USD
CY2014Q2 tbio Inventory Provision Write Offs
InventoryProvisionWriteOffs
6000 USD
tbio Inventory Provision Write Offs
InventoryProvisionWriteOffs
11000 USD
CY2015Q2 tbio Inventory Provision Write Offs
InventoryProvisionWriteOffs
8000 USD
tbio Inventory Provision Write Offs
InventoryProvisionWriteOffs
35000 USD
tbio Issuance Of Warrants Expected Exercise Period
IssuanceOfWarrantsExpectedExercisePeriod
P1Y7M10D
CY2014Q2 tbio Other Income Expense
OtherIncomeExpense
54000 USD
tbio Other Income Expense
OtherIncomeExpense
-78000 USD
CY2015Q2 tbio Other Income Expense
OtherIncomeExpense
-456000 USD
tbio Other Income Expense
OtherIncomeExpense
-804000 USD
tbio Percent Of Revenue From Countries Not Separately Disclosed
PercentOfRevenueFromCountriesNotSeparatelyDisclosed
0.05
CY2014 tbio Preferred Stock Issued During Period Value New Issues
PreferredStockIssuedDuringPeriodValueNewIssues
6905000 USD
CY2014Q2 tbio Provisionfor Doubtful Accounts Excluding Amounts Not Includedin Provision
ProvisionforDoubtfulAccountsExcludingAmountsNotIncludedinProvision
850000 USD
tbio Provisionfor Doubtful Accounts Excluding Amounts Not Includedin Provision
ProvisionforDoubtfulAccountsExcludingAmountsNotIncludedinProvision
1523000 USD
CY2015Q2 tbio Provisionfor Doubtful Accounts Excluding Amounts Not Includedin Provision
ProvisionforDoubtfulAccountsExcludingAmountsNotIncludedinProvision
1198000 USD
tbio Provisionfor Doubtful Accounts Excluding Amounts Not Includedin Provision
ProvisionforDoubtfulAccountsExcludingAmountsNotIncludedinProvision
2730000 USD
CY2014Q2 tbio Stock Warrants Revaluation
StockWarrantsRevaluation
200000 USD
tbio Stock Warrants Revaluation
StockWarrantsRevaluation
250000 USD
CY2015Q2 tbio Stock Warrants Revaluation
StockWarrantsRevaluation
-270000 USD
tbio Stock Warrants Revaluation
StockWarrantsRevaluation
-415000 USD
CY2015Q2 tbio Working Capital
WorkingCapital
2200000 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4871000 USD
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4743000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7627000 USD
CY2015Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9719000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2550000 USD
CY2015Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2698000 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13764000 USD
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14076000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
340000 USD
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
348000 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
189680000 USD
CY2015Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
197187000 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
977000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
328000 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3838000 USD
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3540000 USD
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4041000 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7947000 USD
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
9193000 USD
CY2015Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
8426000 USD
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
349000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1320000 USD
CY2015Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1965000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
2251000 USD
CY2014Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
700000 USD
CY2015Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
800000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5510255 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8286963 shares
CY2014Q2 us-gaap Assets
Assets
31091000 USD
CY2014Q4 us-gaap Assets
Assets
30006000 USD
CY2015Q2 us-gaap Assets
Assets
31409000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
13432000 USD
CY2015Q2 us-gaap Assets Current
AssetsCurrent
15473000 USD
CY2014Q2 us-gaap Capital Leases Income Statement Amortization Expense
CapitalLeasesIncomeStatementAmortizationExpense
100000 USD
us-gaap Capital Leases Income Statement Amortization Expense
CapitalLeasesIncomeStatementAmortizationExpense
100000 USD
CY2015Q2 us-gaap Capital Leases Income Statement Amortization Expense
CapitalLeasesIncomeStatementAmortizationExpense
100000 USD
us-gaap Capital Leases Income Statement Amortization Expense
CapitalLeasesIncomeStatementAmortizationExpense
100000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1626000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1191000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1609000 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2309000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-435000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
700000 USD
CY2014Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
10.25
CY2014Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.73
CY2014Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
10.86
CY2015Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
7.56
CY2015Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
9.59
CY2014Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1387685 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1212665 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1309785 shares
CY2015Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1881396 shares
CY2015Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1483161 shares
CY2015Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4093477 shares
us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P2Y0M
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8084471 shares
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12328918 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8084471 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12328918 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
81000 USD
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
123000 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3871000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8035000 USD
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3233000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6308000 USD
CY2014Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4371000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8128000 USD
CY2015Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4168000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7707000 USD
CY2014Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
7837000 USD
CY2015Q2 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
7675000 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1012000 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1035000 USD
CY2015Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
952000 USD
CY2014Q2 us-gaap Depreciation
Depreciation
100000 USD
us-gaap Depreciation
Depreciation
200000 USD
CY2015Q2 us-gaap Depreciation
Depreciation
100000 USD
us-gaap Depreciation
Depreciation
200000 USD
CY2014Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
488000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
981000 USD
CY2015Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
558000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1111000 USD
CY2014Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
3130000 USD
CY2015Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
0 USD
CY2014 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
1144000 USD
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
-3130000 USD
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.57
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.17
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.65
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
13000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
2000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0141
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1129000 USD
CY2015Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1028000 USD
CY2015Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
800000 USD
us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
1.01
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-250000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
415000 USD
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-100000 USD
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-100000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.005
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5970000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6632000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
900000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1100000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1400000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1400000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
13934000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
14181000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7964000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7549000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-14000 USD
CY2014Q4 us-gaap Goodwill
Goodwill
6918000 USD
CY2015Q2 us-gaap Goodwill
Goodwill
6918000 USD
CY2014Q2 us-gaap Gross Profit
GrossProfit
2393000 USD
us-gaap Gross Profit
GrossProfit
4887000 USD
CY2015Q2 us-gaap Gross Profit
GrossProfit
2872000 USD
us-gaap Gross Profit
GrossProfit
5846000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3901000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7572000 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3233000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6228000 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
497000 USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
88000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
667000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-131000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3479000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3994000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-550000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-81000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
145000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
61000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
88000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-42000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
66000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
0 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-146000 USD
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7964000 USD
CY2015Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7549000 USD
CY2014Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-146000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-328000 USD
CY2015Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-186000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-376000 USD
us-gaap Interest Paid
InterestPaid
147000 USD
us-gaap Interest Paid
InterestPaid
222000 USD
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2139000 USD
CY2015Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1977000 USD
CY2014Q4 us-gaap Inventory Gross
InventoryGross
3633000 USD
CY2015Q2 us-gaap Inventory Gross
InventoryGross
3540000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
3005000 USD
CY2015Q2 us-gaap Inventory Net
InventoryNet
2619000 USD
CY2013Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
799000 USD
CY2014Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
849000 USD
CY2014Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
843000 USD
CY2014Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
628000 USD
CY2015Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
601000 USD
CY2015Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
921000 USD
CY2014Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
1302000 USD
CY2015Q2 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
1203000 USD
us-gaap Inventory Write Down
InventoryWriteDown
55000 USD
us-gaap Inventory Write Down
InventoryWriteDown
328000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
23453000 USD
CY2015Q2 us-gaap Liabilities
Liabilities
20485000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30006000 USD
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31409000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11115000 USD
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
13313000 USD
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
462000 USD
CY2015Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
2825000 USD
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7375000 USD
CY2015Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4850000 USD
CY2014Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
11369000 USD
CY2015Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
11519000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6981000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6950000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-172000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-240000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7257000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6012000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-3893000 USD
us-gaap Net Income Loss
NetIncomeLoss
-8069000 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-13942000 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-3275000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6316000 USD
CY2014Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4198000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8604000 USD
CY2015Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3606000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6978000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
6348000 USD
us-gaap Operating Expenses
OperatingExpenses
12381000 USD
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
5649000 USD
us-gaap Operating Expenses
OperatingExpenses
11270000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3955000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-7494000 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2777000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5424000 USD
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
200000 USD
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
500000 USD
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
800000 USD
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
900000 USD
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
600000 USD
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
500000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
400000 USD
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1191000 USD
CY2015Q2 us-gaap Other Assets Current
OtherAssetsCurrent
826000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
210000 USD
CY2015Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
149000 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
22000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
34000 USD
CY2014 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-50000 USD
CY2015Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
42000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8000 USD
CY2014Q4 us-gaap Other Inventory Demo
OtherInventoryDemo
192000 USD
CY2015Q2 us-gaap Other Inventory Demo
OtherInventoryDemo
360000 USD
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1068000 USD
CY2015Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1067000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1688000 USD
CY2015Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1762000 USD
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
62000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
46000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
110000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
194000 USD
CY2014Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
305000 USD
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
535000 USD
CY2015Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
331000 USD
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
662000 USD
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4029502 shares
CY2015Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4029502 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4029502 shares
CY2015Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4029502 shares
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
40000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
923000 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15246000 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1012000 USD
CY2015Q2 us-gaap Preferred Stock Value
PreferredStockValue
40000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6209000 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
6906000 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
4440000 USD
CY2015Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15396000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1482000 USD
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1320000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1523000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1909000 USD
CY2015Q2 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
1200000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
82000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
34000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
4283000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
148000 USD
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
785000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1530000 USD
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
576000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1143000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-183588000 USD
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-186774000 USD
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
6764000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
13015000 USD
CY2015Q2 us-gaap Sales Revenue Net
SalesRevenueNet
7040000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
13553000 USD
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5563000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10851000 USD
CY2015Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5073000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10127000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
637000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
322000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P1Y4M10D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.83
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0132
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
350213 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.41
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
49198 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
18397 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
214296 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
596560 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
608910 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
685984 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1227299 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.56
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.95
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
100000 USD
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1140292 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
9.99
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.08
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.50
CY2015Q2 us-gaap Share Price
SharePrice
1.67
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y2M25D
CY2014 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2361000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6209000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
11446000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
6553000 USD
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
10924000 USD
CY2014Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0833
CY2014Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
145000 USD
CY2015Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
560000 USD
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7353695 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7353695 shares
CY2015Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12149632 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10778857 shares
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting period. In addition, estimates and assumptions associated with the determination of the fair value of certain assets and related impairments require considerable judgment by management. Actual results could differ from the estimates and assumptions used in preparing these condensed consolidated financial statements.</font></div></div>

Files In Submission

Name View Source Status
0001043961-15-000014-index-headers.html Edgar Link pending
0001043961-15-000014-index.html Edgar Link pending
0001043961-15-000014.txt Edgar Link pending
0001043961-15-000014-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tbio-20150630.xml Edgar Link completed
tbio-20150630.xsd Edgar Link pending
tbio-20150630x10q.htm Edgar Link pending
tbio-20150630_cal.xml Edgar Link unprocessable
tbio-20150630_def.xml Edgar Link unprocessable
tbio-20150630_lab.xml Edgar Link unprocessable
tbio-20150630_pre.xml Edgar Link unprocessable
tbio-ex311_20150630x10q.htm Edgar Link pending
tbio-ex321_20150630x10q.htm Edgar Link pending